OTLK icon

Outlook Therapeutics
OTLK

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$4.5
128% upside
High target

2 analyst ratings

positive
1  neutral
50%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
HC Wainwright & Co
HC Wainwright & Co
Douglas Tsao
0% 1-yr OTLK win rate
30 Sep ‘25 2 months ago
Ascendiant Capital
Ascendiant Capital
Edward Woo
67% 1-yr OTLK win rate
22 Sep ‘25 2 months ago